Cardiovascular
Cardioprotective and vascular research. Reference only.
Ranking reflects how much cited material this reference holds for the goal — how many indications are recorded and how strong the reported effects were. It is a measure of documentation, not a safety or efficacy endorsement, and a compound can rank highly on preclinical work alone.
12345678910111213
Retatrutide
Lipid Improvement · Blood Pressure Optimization · Hepatic Fat Reduction
3 indications · 6 refs
SS-31
Cardiac Protection · Heart Failure Support · Exercise Tolerance
3 indications · 6 refs
Tirzepatide
MACE Reduction · Blood Pressure Reduction · Lipid Profile Improvement
3 indications · 8 refs
B7-33
Cardiac Fibrosis · Vasodilation · Heart Failure
3 indications · 5 refs
VIP
Pulmonary Hypertension · Vasodilation · Cardiac Support
3 indications · 0 refs
Cardiogen
Cardiac Tissue Repair · Myocardial Function · Cardiovascular Aging
3 indications · 0 refs
Hexarelin
Cardioprotection · Cardiomyocyte Protection · Calcium Channel Modulation
3 indications · 0 refs
Vesugen
Vascular Aging · Atherosclerosis Prevention · Endothelial Function
3 indications · 0 refs
Mazdutide
Blood Pressure Reduction · Lipid Profile Enhancement
2 indications · 0 refs
SLU-PP-332
Cardiac Function Improvement
1 indication · 4 refs
TB-500 (Ac-LKKTETQ)
Angiogenesis
1 indication · 0 refs
Thymosin Beta-4
Cardiac Protection Post-MI
1 indication · 0 refs
AICAR
Ischemia Protection
1 indication · 0 refs